A key to a ‘faulty’ lock: Why Aussie researchers are excited about naltrexone for CFS

Ausdoc.com
31 July 2023
https://www.ausdoc.com.au/news/a-key-to-a-faulty-lock-why-aussie-researchers-are-excited-about-naltrexone-for-cfs/

Off-Label Meds: Promising Long COVID Treatments?

Medscape
28 July 2023
https://www.medscape.com/viewarticle/994728?form=fpf

With a lack of FDA-approved treatments, doctors who treat long COVID are turning to off-label use of drugs designed for addiction, diabetes, and other conditions.The FDA approves each drug to treat a specific condition. Off-label use, which is legal and common, allows doctors to prescribe drugs for another use.

Queensland scientists push for new national treatment guidelines for chronic fatigue syndrome

ABC News
12 June 2023
https://www.abc.net.au/news/2023-06-13/griffith-university-scientists-researching-chronic-fatigue-mecfs/102471386

Largest medical research grant to help ME/CFS and Long COVID research

Griffith News
19 April 2023
https://news.griffith.edu.au/2023/04/19/largest-medical-research-grant-to-help-me-cfs-and-long-covid-research/

Treating Long-COVID Brain Fog With ME/CFS Guidelines

Medscape
27 March 2023
https://www.medscape.com/viewarticle/989887

Cognitive symptoms, commonly referred to as brain fog, are among the most common persistent or new symptoms after COVID-19. Cognitive symptoms are also often reported by patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

An Update on the Uses of Naltrexone in Clinical Practice

Natural Medicine Journal
01 August 2022
https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice

Long COVID: major findings, mechanisms and recommendations

Nature reviews: microbiology
13 January 2023
https://www.nature.com/articles/s41579-022-00846-2